Spot Trading L.L.C - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 114 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2014. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
Spot Trading L.L.C ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2017$280,000
-80.4%
26,700
-70.2%
0.01%
-64.0%
Q1 2016$1,431,000
+46.8%
89,461
+162.5%
0.02%
+150.0%
Q4 2015$975,000
+55.0%
34,081
+128.5%
0.01%
+150.0%
Q4 2014$629,000
+109.7%
14,916
+93.3%
0.00%
+300.0%
Q3 2014$300,0007,7160.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q4 2014
NameSharesValueWeighting ↓
Consonance Capital Management LP 3,257,094$92,697,00013.04%
JW Asset Management, LLC 388,346$11,052,0004.00%
Anson Funds Management LP 400,200$11,390,0003.31%
Orbimed Advisors 4,081,800$116,168,0001.17%
SCOPIA CAPITAL MANAGEMENT LP 1,718,487$48,908,0001.05%
Bellevue Asset Management AG 210,000$5,977,0000.98%
NEXT CENTURY GROWTH INVESTORS LLC 788,534$22,441,0000.93%
Rock Springs Capital Management LP 308,000$8,766,0000.71%
JUNCTURE WEALTH STRATEGIES, LLC 18,502$527,0000.43%
B. Riley Wealth Management, Inc. 8,600$244,0000.35%
View complete list of INSYS THERAPEUTICS INC NEW shareholders